Skip navigation

From Nature: Computer-Calculated Compounds

The aim of BERG’s approach is to identify potential treatments on the basis of the precise biological causes of disease. “We are turning the drug-discovery paradigm upside down by using patient-driven biology and data to derive more predictive hypotheses, rather than the traditional trial-and-error approach,” says Niven R. Narain, BERG’s co-founder and CEO.

This Nature piece goes on to note how researchers are using AI to discover drugs, and specifically highlight’s BERG and Niven R. Narain in their “Spotlight” feature.

To read the full article, click here.